<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ischemic postconditioning has been described in both heart and brain </plain></SENT>
<SENT sid="1" pm="."><plain>The first aim of this study was to evaluate the effects of <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> postconditioning (SP) on brain biochemical parameters, Bcl-2, Bax, c-Fos and Caspase-3 protein levels and Bcl-2, Bax, TNF-α and Caspase-3 mRNA expression in the middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="2" pm="."><plain>Results showed that SP markedly decreased cerebral oxidative injury and improved immunity activity </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, SP significantly enhanced cerebral Bcl-2, c-Fos and decreased Bax, Caspase-3 proteins positive expression </plain></SENT>
<SENT sid="4" pm="."><plain>Reverse transcription polymerase chain reaction analysis showed that SP markedly enhanced Bcl-2, and decreased Bax, TNF-α and Caspase-3 mRNA expression </plain></SENT>
<SENT sid="5" pm="."><plain>Our results confirm that SP can play the protective action against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion-induced brain injury by regulating cerebral <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes activities, Bcl-2, Bax, c-Fos and Caspase-3 protein positive expression levels and Bcl-2, Bax, TNF-α and Caspase-3 mRNA expression </plain></SENT>
</text></document>